BIOLASE INC (BIOL) Stock Price, Quote, News and Overview
NASDAQ:BIOL - Nasdaq - US0909117022 - Common Stock - Currency: USD
BIOL Quote, Performance and Key Statistics
0.129
-0.02 (-13.19%)
The current stock price of BIOL is 0.129 USD. In the past month the price decreased by -19.73%. In the past year, price decreased by -98.35%.
BIOL Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About BIOL
Company Profile
BIOLASE Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Foothill Ranch, California and currently employs 188 full-time employees. BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft tissue) systems. The Waterlase brand uses a combination of water and laser energy and performs using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The firm also offers diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company also manufactures and sells consumable products and accessories for its laser systems. Its Waterlase and diode systems use disposable laser tips of differing sizes and shapes.
Company Info
BIOLASE INC
27042 Towne Centre Drive, Suite 270
Foothill Ranch CALIFORNIA 92610 US
CEO: John R. Beaver
Employees: 188
Company Website: https://www.biolase.com/
Phone: 19493611200
BIOLASE INC / BIOL FAQ
What is the stock price of BIOLASE INC today?
The current stock price of BIOL is 0.129 USD. The price decreased by -13.19% in the last trading session.
What is the ticker symbol for BIOLASE INC stock?
The exchange symbol of BIOLASE INC is BIOL and it is listed on the Nasdaq exchange.
On which exchange is BIOL stock listed?
BIOL stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for BIOLASE INC stock?
9 analysts have analysed BIOL and the average price target is 1.99 USD. This implies a price increase of 1441.86% is expected in the next year compared to the current price of 0.129. Check the BIOLASE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BIOLASE INC worth?
BIOLASE INC (BIOL) has a market capitalization of 4.31M USD. This makes BIOL a Nano Cap stock.
How many employees does BIOLASE INC have?
BIOLASE INC (BIOL) currently has 188 employees.
What are the support and resistance levels for BIOLASE INC (BIOL) stock?
BIOLASE INC (BIOL) has a resistance level at 0.16. Check the full technical report for a detailed analysis of BIOL support and resistance levels.
Is BIOLASE INC (BIOL) expected to grow?
The Revenue of BIOLASE INC (BIOL) is expected to grow by 2.98% in the next year. Check the estimates tab for more information on the BIOL EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BIOLASE INC (BIOL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BIOL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BIOL, evaluating the profitability, health, valuation and growth aspects
- BIOLASE INC (BIOL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIOLASE INC (BIOL) Sales and EPS estimates to see what analysts future expectations are.
- BIOLASE INC (BIOL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIOLASE INC (BIOL) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIOLASE INC (BIOL) Stock Chart to make your own analysis
- BIOLASE INC (BIOL) Latest news and press-releases to stay up to date.
Does BIOLASE INC (BIOL) stock pay dividends?
BIOL does not pay a dividend.
When does BIOLASE INC (BIOL) report earnings?
BIOLASE INC (BIOL) will report earnings on 2024-08-08, after the market close.
What is the Price/Earnings (PE) ratio of BIOLASE INC (BIOL)?
BIOLASE INC (BIOL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-14.25).
BIOL Technical Analysis
BIOL Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to BIOL. BIOL may be in some trouble as it scores bad on both profitability and health.
BIOL Financial Highlights
Over the last trailing twelve months BIOL reported a non-GAAP Earnings per Share(EPS) of -14.25. The EPS increased by 95.89% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -111.37% | ||
| ROE | -14222.3% | ||
| Debt/Equity | 41.66 |
BIOL Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to BIOL. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 98.59% and a revenue growth 2.98% for BIOL